Table 1.

Characteristic of pregnant CCHF cases.

Authors	Country	Year (s)	No. cases	Diagnosis	Age	Gestation	Maternal outcome	Hemorr-hage	Fetal/Neo-natal outcome	Ribavirin	Secondary cases
Al-Tikriti SK et al.31	Iraq	1979	3	Viral culture/clinical	ND	ND	Died	Yes	Died	No	No
					ND	ND	Died	Yes	Died	No	No
					ND	ND	Survived	Yes	Died	No	No
Baljosevic. S et al.32	Former Yugoslavia	1986–1995	4	UK	29	32/40	Died	Yes	Died	ND	ND
					30	24/40	Died	Yes	Died	ND	ND
					39	38/40	Died	Yes	Died	ND	ND
					24	11/40	Survived	Yes	Died	ND	ND
Sharif-Mood B et al.11	Iran	2000–2005	6	PCR/Serology	19–38	ND	Survived	Yes	Died	Yes	No
				PCR/Serology		ND	Survived	Yes	Died	Yes	No
				PCR/Serology		ND	Survived	Yes	Died	Yes	No
				PCR/Serology		ND	Survived	Yes	Survived	Yes	No
				PCR/Serology		ND	Survived	Yes	Survived	Yes	No
				PCR/Serology		16/40	Died	Yes	Died	Yes	No
Nabeth P et al.19	Mauritania	2003	2	Clinical	30	ND	Died	Yes	Died	No	Yes (19)
				Clinical	ND	ND	ND	ND	ND	No	ND
Ergonul O et al.9	Turkey	2003–2008	3	Serology	40	38/40	Survived	Yes	Died	Yes	No
				PCR	20	19/40	Survived	Yes	Died	No	No
				PCR/Serology	28	28/40	Died	Yes	Died	No	No
Gozel MG et al.10	Turkey	2007–2011	5	PCR/Serology	35	8/40	Survived	Yes	Died	No	No
				PCR/Serology	30	18/40	Survived	No	Survived	No	No
				PCR	41	20/40	Survived	No	Survived	No	No
				PCR/Serology	19	21/40	Survived	No	Survived	No	No
				PCR/Serology	27	33/40	Survived	No	Survived	No	No
Oskooei HO et al.33	Iran	2008	1	Serology	UK	UK	Survived	No	Survived	Yes	No
Dizbay M et al.34	Turkey	2009	1	PCR/Serology	22	36/40	Survived	Yes	Survived	Yes	No
Naderi HR et al.18	Iran	2009	2	(PCR +ve secondary cases)	UK	ND	Died	Yes	Died	No	Yes (1)
					31	ND	Died	Yes	Died	No	Yes (4)
Mumdchiev-a H et al.35	Bulgaria	2009	1	PCR/Serology	UK	26/40	Survived	Yes	Survived	UK	No
Aydemir O et al.36	Turkey	2010	1	PCR	29	30/40	Survived	No	Survived	No	No
Pshenichnya N et al.2	Russia	2011	1	PCR	23	22/40	Died	Yes	Died	No	Yes (8)
Mardani M et al.37	Iran	2011	1	PCR/Serology	24	16/40	Survived	Yes	Survived	Yes	No
Duygu F et al.38	Turkey	2011	2	PCR	25	17/40	Survived	Yes	Survived	No	No
				PCR	22	20/40	Survived	No	Survived	No	No
Ünlüsoy-Aksu A et al.39	Turkey	2014	1	PCR	23	36/40	Survived	Yes	Survived	Yes	No
Pschenichnaya N et al.	Russia	2002	8	PCR/Serology	20	16/40	Survived	No	Survived	No	No
	Russia	2003		Serology	19	38/40	Survived	No	Survived	Yes	No
	Russia	2004		PCR	17	30/40	Died	Yes	Died	No	No
	Russia	2005		Serology	24	17/40	Survived	Yes	Died	No	No
	Kazakhstan	2009		Immunohist	23	40/40	Died	Yes	Died	No	Yes (5)
	Kazakhstan	2010		Immunohist	21	34/40	Died	Yes	Died	No	Yes (1)
	Russia	2011		PCR	17	18/40	Survived	No	Survived	Yes	No
	Turkey	2016		PCR	20	04/40	Survived	Yes	Died	No	No

ND – Not determined. PCR – polymerase chain reaction, Immunohist – Immunohistochemistry.